2023
Pediatric neurovascular complication of SARS-CoV-2 infection: A single Center Case-Series.
MUŽLAYOVÁ, Patrícia, Klára ŠPANĚLOVÁ, Tamara SKŘÍŠOVSKÁ, Ondřej HORÁK, Jan ŠENKYŘÍK et. al.Základní údaje
Originální název
Pediatric neurovascular complication of SARS-CoV-2 infection: A single Center Case-Series.
Autoři
MUŽLAYOVÁ, Patrícia, Klára ŠPANĚLOVÁ, Tamara SKŘÍŠOVSKÁ, Ondřej HORÁK, Jan ŠENKYŘÍK, Anna SEEHOFNEROVÁ, Lukáš HOMOLA, Jozef KLUČKA, Jan BLATNÝ, Hana OŠLEJŠKOVÁ a Pavlína DANHOFER
Vydání
15th Congress of the European Pediatric Neurology Society (EPNS), Prague, 2023
Další údaje
Jazyk
angličtina
Typ výsledku
Konferenční abstrakt
Obor
30209 Paediatrics
Stát vydavatele
Česká republika
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Organizační jednotka
Lékařská fakulta
Klíčová slova anglicky
Brain vasculopathy; COVID-19; Children; SARS-CoV-2; Stroke.
Změněno: 5. 4. 2024 10:12, Mgr. Tereza Miškechová
Anotace
V originále
SARS-CoV-2 virus causing Coronavirus disease 2019 (COVID-19) like other coronaviruses mainly targets the respiratory system. In symptomatic patients, the most common manifestation is fever, fatigue, cough, and headache. Severe forms can present with pneumonia, acute respiratory distress syndrome, acute cardiac dysfunction, and multiorgan failure. Some studies have indicated an association between COVID-19 and neurovascular conditions. These studies report mainly adult patients with a severe course of the infection. SARS-CoV-2 infects the host through its CoV spike glycoprotein, which binds to the angiotensin-converting enzyme 2 (ACE2) receptor, which is expressed in the lungs, heart, and kidneys and in endothelial cells. In general, pathophysiological processes after COVID-19 infection can cause vascular affliction and microvascular dysfunction and coagulation abnormalities. It is broadly believed that children usually have a mild case of SARS-CoV-2 infection. However, in connection with the prolong COVID-19 pandemic, we are more likely to see health conditions that have rarely been seen before and that share a common history of recent COVID-19. These cases are intended to present that the course of this infection may not always be benign and a longer period will be needed to assess the consequences of the infection. Further studies will certainly be needed to address the pathophysiological basis in an effort to ensure its optimal diagnostics and treatment in children. This article presents a case series of 3 children who were diagnosed with cerebrovascular disease and whose common denominator was current or previous infection with SARS-CoV-2